Active Implants’ two clinical trials of the NUsurface® Meniscus Implant – SUN (Safety Using NUsurface®) and VENUS (Verifying the Effectiveness of the NUsurface® System) – completed enrollment in June 2018. The company is expecting to file for approval by the U.S. Food and Drug Administration within the next two years.

To be notified of any future NUsurface Implant developments, please sign up for our mailing list.

CAUTION: Investigational Device. Limited by Federal (US) law to investigational use.